Long‐term follow‐up of a phase 2 study of all‐trans retinoic acid, arsenic trioxide, and gemtuzumab ozogamicin in acute promyelocytic leukemia
The combination of ATO-ATRA and GO was curative in 94% of patients who had APL with a favorable safety profile (ClinicalTrials.gov identifier NCT01409161).
Authors
- Farhad Ravandi (ORCID: https://orcid.org/0000-0002-7621-377X)
- Jennifer Marvin‐Peek (ORCID: https://orcid.org/0000-0001-9595-1279)
- Maro N. Ohanian (ORCID: https://orcid.org/0000-0002-1689-4470)
- Courtney Denton Dinardo (ORCID: https://orcid.org/0000-0001-9003-0390)
- Prithviraj Bose (ORCID: https://orcid.org/0000-0002-4343-5712)
- Wei‐Ying Jen (ORCID: https://orcid.org/0000-0002-9339-3362)
- Fadi Haddad (ORCID: https://orcid.org/0000-0002-9702-8485)
- Steven Mitchell Kornblau (ORCID: https://orcid.org/0000-0002-5990-9548)
- Tapan Mahendra Kadia (ORCID: https://orcid.org/0000-0002-9892-9832)
- Guillermo Montalban‐Bravo (ORCID: https://orcid.org/0000-0002-4533-5176)
- Kelly Sharon Chien (ORCID: https://orcid.org/0000-0001-6024-1613)
- Alessandra Ferrajoli (ORCID: https://orcid.org/0000-0001-9547-4193)
- Koji Sasaki (ORCID: https://orcid.org/0000-0002-9140-0610)
- Naval Guastad Daver (ORCID: https://orcid.org/0000-0001-7103-373X)
- Nitin B. Jain (ORCID: https://orcid.org/0000-0002-4362-8522)
- David McCue
- Elias Joseph Jabbour (ORCID: https://orcid.org/0000-0003-4465-6119)
- Musa E. Yilmaz (ORCID: https://orcid.org/0000-0002-4498-4895)
- Mahesh Swaminathan (ORCID: https://orcid.org/0000-0001-5959-397X)
- Koichi Takahashi (ORCID: https://orcid.org/0000-0002-8027-9659)
- Mark Brandt
- Jan A. Burger (ORCID: https://orcid.org/0000-0002-6177-7572)
- Ghayas C. Issa (ORCID: https://orcid.org/0000-0002-4339-8683)
- Guillermo Garcia‐Manero (ORCID: https://orcid.org/0000-0002-3631-2482)
- Gautam Borthakur
- Yesid Alvarado (ORCID: https://orcid.org/0000-0002-1652-7937)
- Hussein A. Abbas (ORCID: https://orcid.org/0000-0003-2946-3562)
- Abhishek Maiti (ORCID: https://orcid.org/0000-0001-9043-538X)
- Lucia Masárová (ORCID: https://orcid.org/0000-0001-6624-4196)
- Danielle Hammond (ORCID: https://orcid.org/0000-0002-6017-2264)
- Naveen Pemmaraju (ORCID: https://orcid.org/0000-0002-1670-6513)
- Hagop M. Kantarjian (ORCID: https://orcid.org/0000-0002-1908-3307)
- Nicholas James Short (ORCID: https://orcid.org/0000-0002-2983-2738)
- Sherry Pierce
- Keyur Patel
- William G. Wierda
Institutions
- The University of Texas MD Anderson Cancer Center (US)
Publication Details
- Journal
- Cancer
- Published
- 2024-11-25
- DOI
- https://doi.org/10.1002/cncr.35662
- Citations
- 11
- Primary Topic
- Retinoids in leukemia and cellular processes
- Type
- article
- Field-Weighted Citation Impact
- 2.57
Funders
- Pfizer
- University of Texas MD Anderson Cancer Center